News

Under the terms of the divestment, Evotec has acquired the assets and operations associated with the zebrafish business currently located in Oxfordshire, UK and Singapore for GBP500,000 in

This designation covers Trinam as a treatment for the prevention of de novo stenosis at vascular surgical anastamoses. Trinam is an adenovirus-mediated VEGF D gene delivered with a

Both Misonix and Ekrior will share the “fee for use” revenue for the length of the agreement plus any extension periods. Procedure minimums for “fee per use” revenue

Swiss biopharmaceutical company Basilea Pharmaceutica has reported that Toctino, a new once-daily oral treatment for adults with severe chronic hand eczema unresponsive to potent topical corticosteroids, has obtained

US-based healthcare company Myriad Genetics has reported a net profit of $25.31m, or $0.25 per diluted share for the third quarter of fiscal 2009, compared to a net

Novavax, a biotechnology company, has reported vaccination of healthy volunteers in the second clinical trial of its virus-like particle or VLP seasonal influenza vaccine. Building on data from

NiTi Surgical Solutions, a surgical device company, has launched the ColonRing, its new closure technology for colorectal surgery, in the US. The current surgical standard for reconnecting the

Calistoga Pharmaceuticals, a developer of medicines for the treatment of cancer and inflammatory diseases, has closed a $30m series B financing.Investors participating in the financing include Alta Partners,

Teva Pharmaceutical Industries, an Israeli pharmaceutical company, has reported a net income of $451m, or $0.51 diluted earnings per share, for the first quarter of 2009 compared to